The intersection of reproductive endocrinology & women's health with diabetes presents unique challenges across different life stages. Polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM) are common metabolic disorders linked to insulin resistance, affecting fertility and pregnancy outcomes. Hormonal fluctuations influence glycemic control, making diabetes management more complex during puberty, pregnancy, and menopause. Emerging research highlights the impact of sex hormones on glucose metabolism and the role of individualized treatment approaches in optimizing reproductive health. Advancements in assisted reproductive technologies, targeted hormonal therapies, and lifestyle interventions improve fertility outcomes and maternal health. A comprehensive approach integrating endocrinology, obstetrics, and metabolic management is essential for addressing these challenges effectively.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti